This website does not support Internet Explorer. Please, switch to Edge, Chrome, or Firefox browser to view this page.

Learn about IE support
O9 whitepaper biopharma mockup
White paper

Addressing biopharma supply chain complexity to create a strategic advantage

  • Learn how biopharma companies can address the increasing complexity in their supply chains.

I agree to the privacy policy.

Kyowa Kirin
Mankind Pharma
Kobayashi Pharma
CooperVision
Intuitive Surgical
ResMed
Marks & Spencer
Mondelez International
Kyowa Kirin
Mankind Pharma
Kobayashi Pharma
CooperVision
Intuitive Surgical
ResMed
Marks & Spencer
Mondelez International
Trusted by leaders across industry verticals

What you will learn

Solve biopharma issues

The current state of the biopharma industry, including the latest innovations driving supply chain complexity.

Manage complexity

The five key drivers and challenges driving complexity in the biopharma supply chain and why should the industry focus on managing them.

Effective strategy

The key value drivers required to effectively address biopharma supply chain complexity to create a strategic advantage.

Patient-centric therapies through innovation

Patient-centric therapies through innovation

The biopharmaceutical industry is evolving toward highly personalized patient-centric therapies. While these next-generation treatments have brought newfound hope to patients, they add complexity to one of the most intricate and high stakes supply chains. Each product can have hundreds of variants depending on the process complexity, country, quality standards, and regulatory approvals across the end-to-end product flow.

Pharmaceutical manufacturing

Out with the Excel and gain greater visibility

Out with the Excel and gain greater visibility

Additionally, a fragmented IT landscape, a reliance on manual spreadsheet-based planning processes, and a lack of visibility and collaboration with external partners greatly hinder biopharma companies’ supply chain planning and decision-making abilities.

Learn about the factors driving biopharmaceutical supply chain complexity and how the industry can address them to create a strategic advantage.

Person working in a laboratory
Ibm whitepaper 2 1

Addressing biopharma supply chain complexity to create a strategic advantage

Learn how biopharma companies can address the increasing complexity in their supply chains.

I agree to the privacy policy.

Resources

View our related articles, white papers, use cases & videos

White Paper

Go digital: supply chain transformation in the Capital Goods industry UG

Stock 2
White Paper

Go digital: supply chain transformation in the Capital Goods industry

O9 whitepaper genpact mockup
article

Addressing Medtech Supply Chain Complexity: A Five-Point Guide

by Vijay Mohan
Modern equipment in operating room. medical devices for neurosurgery.
article

What are the key drivers of biopharma supply chain complexity?

by Vijay Mohan
Chemische produktion
news

o9 Expands Its Collaboration With Microsoft to Advance Generative AI Capabilities in the o9 Digital Brain Planning Platform With Microsoft Azure OpenAI Service

by o9 Solutions
Microsoft genai newsroom banner v1 (1)
Guide

The complete guide to replacing SAP APO in 2024

Apo guide
© – o9 Solutions, Inc.
Privacy Policy Cookie policy Support o9 Guide
tree nation
tree nation